Chain Pharmacy Category Reviews: Hatch-Waxman Act 30 years later
11/8/2014
DSN examines chain pharmacy, including in-depth coverage of pharmacy technology, biosimilars and generics, as well as a look at the impact of the Hatch-Waxman act and Q&A's with industry leaders, in this multi-page report.